| VIM | CK5 | CK6 | CK7 | CK8/18 | CK14 | CK19 | P63 | S100 | CD10 | ER | PG | HER-2 |
---|
EM |
-
|
−/+
|
+
|
+
|
-
|
+
|
-
|
−/+
|
−/+
|
-
|
-−/+
|
-
|
-
|
EB |
-
|
−/+
|
−/+
|
+
|
−/+
|
+
|
−/+
|
-
|
-
|
-
|
−/+
|
−/+
|
−/+
|
MM |
+
|
-
|
+
|
−/+
|
-
|
-
|
-
|
+
|
+
|
+
|
-−/+
|
-
|
-
|
MB |
+
|
−/+
|
+
|
−/+
|
-
|
-
|
-
|
+
|
+
|
+
|
-−/+
|
-
|
-
|
- Legend:
- EM, epithelial malignant component.
- EB, epithelial benign component.
- MM, myoepithelial malignant component.
- MB myoepithelial benign component.
- negative (−) antibody was not found in any cell.
- largely positive (+) > 75% of the cells were positive.
- locally positive (−/+) 25 to 75% of the cells were positive.
- focally positive (−/+) < 25% of the cells were positive.